Poseida Therapeutics has filed a notice of an exempt offering of securities to raise $24,999,999.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Poseida Therapeutics is raising $24,999,999.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Eric Ostertag played a key role…
